Clinical Trial Update: Liquid Biopsy for Detection of Driver Mutation in NSCLC

View source ↗

Summary

This document provides an update on a clinical trial evaluating liquid biopsy for detection of driver mutations in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Non Small Cell Lung Cancer | Status: UNKNOWN